Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Aurobindo Pharma LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524804NSE Symbol: AUROPHARMAP/E(TTM):33.45
ISIN Demat:INE406A01037Div & Yield %:0EPS(TTM):33.74
Book Value(Rs):350.4569173Market Cap ( Cr.):66123.17Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 10933.3010645.648457.0011287.1415823.6813370.77
Excise Duty0.000.000.000.000.000.00
Net Sales10933.3010645.648457.0011287.1415823.6813370.77
Other Income 328.12670.10443.92670.99589.86388.79
Stock Adjustments 67.66116.23263.95-45.51-2.99238.67
Total Income11329.0811431.979164.8711912.6216410.5513998.23
EXPENDITURE :      
Raw Materials 5675.345964.484755.955800.747241.836819.85
Power & Fuel Cost185.59191.58167.86477.99512.34526.31
Employee Cost 1063.07980.56890.531600.041735.421577.14
Other Manufacturing Expenses 426.63414.51328.42705.68925.86814.44
Selling and Administration Expenses 960.27822.21939.381009.361069.84938.36
Miscellaneous Expenses 132.49164.49148.96249.13215.57235.47
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure8443.398537.837231.109842.9411700.8610911.57
Operating Profit2885.692894.141933.772069.684709.693086.66
Interest 230.04182.6074.5816.9428.68243.28
Gross Profit2655.652711.541859.192052.744681.012843.38
Depreciation297.20254.58243.26415.26488.00473.33
Profit Before Tax2358.452456.961615.931637.484193.012370.05
Tax627.37598.08412.16379.701043.34492.28
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-15.71-95.26-23.34-196.9336.760.89
Reported Net Profit1746.791954.141227.111454.713112.911876.88
Extraordinary Items 5.483.289.94-81.27-0.13-1.90
Adjusted Net Profit1741.311950.861217.171535.983113.041878.78
Adjst. below Net Profit -5.26-1.698.281.69-6.42-44.88
P & L Balance brought forward18348.8716660.0815864.1414671.4111799.3010143.08
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.00263.66439.45263.67234.38175.78
P & L Balance carried down20090.4018348.8716660.0815864.1414671.4111799.30
Dividend0.00263.66439.450.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.00450.00750.00900.00400.00300.00
Earnings Per Share-Unit Curr30.0833.3520.9424.8353.1332.03
Earnings Per Share(Adj)-Unit Curr30.0833.3520.9424.8353.1332.03
Book Value-Unit Curr353.55336.62307.80292.15271.80222.78